0519

COM:LGHNH

LG생활건강

  • Stock

Last Close

331.50K

01/11 01:00

Market Cap

5.62T

Beta: -

Volume Today

21.27K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
346.18B
-
393.46B
13.66%
426.28B
8.34%
488.57B
14.61%
541.40B
10.81%
580.83B
7.28%
680.54B
17.17%
777.64B
14.27%
904.81B
16.35%
978.04B
8.09%
477.72B
51.16%
average payables
185.08B
-
204.97B
10.75%
212.43B
3.64%
222.95B
4.95%
230.03B
3.17%
223.54B
2.82%
253.13B
13.24%
270.93B
7.03%
260.88B
3.71%
241.88B
7.28%
106.59B
55.93%
average receivables
423.55B
-
447.68B
5.70%
453.32B
1.26%
491.28B
8.37%
542.26B
10.38%
612.32B
12.92%
678.16B
10.75%
686.39B
1.21%
659.11B
3.97%
643.98B
2.30%
324.03B
49.68%
book value per share
84.03K
-
97.66K
16.23%
121.56K
24.46%
151.10K
24.31%
178.83K
18.35%
209.57K
17.19%
247.45K
18.07%
283.80K
14.69%
321.52K
13.29%
318.50K
0.94%
capex per share
-8.46K
-
-11.50K
35.94%
-18.40K
59.92%
-20.27K
10.15%
-17.35K
14.37%
-21.73K
25.22%
-19.99K
7.98%
-30.96K
54.86%
-19.82K
35.98%
-9.93K
49.91%
capex to depreciation
-1.29
-
-1.59
23.73%
-2.43
52.38%
-2.54
4.69%
-1.99
21.81%
-2.31
16.44%
-1.33
42.28%
-1.98
48.24%
-1.21
38.96%
-0.58
52.15%
capex to operating cash flow
-0.36
-
-0.41
13.67%
-0.48
16.75%
-0.48
1.53%
-0.40
16.94%
-0.45
12.70%
-0.29
34.02%
-0.52
75.63%
-0.34
34.65%
-0.33
0.81%
capex to revenue
-0.03
-
-0.04
25.74%
-0.06
40.32%
-0.06
3.69%
-0.05
16.78%
-0.05
16.36%
-0.04
19.21%
-0.07
51.72%
-0.04
37.93%
-0.02
43.58%
cash per share
9.28K
-
21.26K
129.18%
25.53K
20.06%
21.82K
14.51%
24.05K
10.21%
24.68K
2.60%
42.93K
73.96%
29.40K
31.52%
49.52K
68.46%
40.39K
18.44%
days of inventory on hand
67.48
-
71.43
5.85%
72.35
1.29%
80.36
11.07%
81.12
0.94%
83.22
2.59%
93.38
12.21%
99.66
6.72%
120.15
20.56%
110.06
8.40%
days payables outstanding
36.36
-
36.04
0.90%
35.64
1.11%
34.27
3.82%
34.34
0.18%
29.18
15.01%
36.37
24.63%
30.94
14.92%
32.49
4.99%
24.56
24.41%
days sales outstanding
37.92
-
34.79
8.26%
31.56
9.28%
31.25
1.00%
32.76
4.83%
35.80
9.29%
32.98
7.88%
31.56
4.30%
28.87
8.55%
32.92
14.04%
debt to assets
0.33
-
0.32
4.18%
0.25
20.25%
0.18
29.93%
0.13
28.34%
0.09
27.82%
0.11
18.34%
0.07
36.16%
0.07
0.17%
0.06
12.18%
debt to equity
0.80
-
0.74
8.11%
0.52
29.43%
0.31
39.78%
0.20
35.74%
0.14
31.99%
0.17
23.37%
0.10
41.70%
0.10
1.78%
0.08
14.34%
dividend yield
0.01
-
0.01
11.32%
0.00
37.14%
0.01
77.30%
0.01
2.28%
0.01
34.02%
0.01
15.93%
0.01
3.60%
0.01
39.95%
0.02
64.61%
earnings yield
0.04
-
0.03
13.97%
0.03
21.81%
0.04
58.64%
0.03
27.31%
0.04
24.94%
0.04
2.30%
0.03
20.21%
0.05
56.36%
0.02
57.33%
enterprise value
10.18T
-
11.32T
11.19%
18.26T
61.39%
14.15T
22.53%
20.33T
43.69%
18.20T
10.47%
21.19T
16.40%
27.18T
28.31%
18.17T
33.15%
11.86T
34.74%
enterprise value over ebitda
16.36
-
17.73
8.32%
22.50
26.92%
14.25
36.67%
19.62
37.69%
15.16
22.70%
14.57
3.89%
18.34
25.82%
11.49
37.32%
12.07
5.04%
ev to operating cash flow
26.13
-
24.29
7.01%
28.63
17.86%
19.83
30.74%
27.64
39.38%
22.27
19.41%
18.59
16.54%
27.05
45.52%
18.46
31.77%
23.84
29.19%
ev to sales
2.35
-
2.42
2.85%
3.43
41.66%
2.32
32.26%
3.24
39.65%
2.70
16.80%
2.76
2.20%
3.47
25.70%
2.25
35.19%
1.65
26.52%
free cash flow per share
14.77K
-
16.28K
10.22%
19.66K
20.76%
22.30K
13.47%
26.53K
18.96%
27.03K
1.87%
48.01K
77.62%
29.00K
39.60%
38.92K
34.23%
19.74K
49.29%
free cash flow yield
0.03
-
0.03
3.05%
0.02
28.35%
0.03
45.82%
0.02
19.01%
0.03
13.09%
0.04
52.27%
0.02
52.98%
0.04
98.22%
0.03
22.74%
graham net net
-76.30K
-
-72.97K
4.37%
-65.94K
9.63%
-51.10K
22.52%
-35.61K
30.31%
-27.72K
22.15%
-38.38K
38.47%
-32.60K
15.06%
-14.76K
54.74%
-11.53K
21.88%
graham number
200.73K
-
214.01K
6.62%
274.08K
28.07%
339.51K
23.87%
381.64K
12.41%
438.29K
14.84%
508.43K
16.00%
551.29K
8.43%
603.79K
9.52%
318.01K
47.33%
income quality
1.07
-
1.31
23.32%
1.36
3.22%
1.23
9.17%
1.19
3.46%
1.18
0.73%
1.45
22.50%
1.24
14.53%
1.14
7.49%
1.92
68.38%
intangibles to total assets
0.37
-
0.35
6.07%
0.33
6.86%
0.32
3.70%
0.29
7.57%
0.29
0.46%
0.28
6.01%
0.30
10.23%
0.29
5.38%
0.29
0.20%
0
100%
interest coverage
13.31
-
13.62
2.39%
20.81
52.76%
44.34
113.05%
66.67
50.37%
102.53
53.78%
84.82
17.27%
97.61
15.08%
102.87
5.39%
47.95
53.39%
interest debt per share
69.73K
-
74.33K
6.60%
65.28K
12.18%
48.58K
25.58%
36.88K
24.09%
29.33K
20.46%
42.67K
45.48%
28.73K
32.68%
31.88K
10.99%
27.30K
14.36%
inventory turnover
5.41
-
5.11
5.53%
5.05
1.28%
4.54
9.97%
4.50
0.93%
4.39
2.52%
3.91
10.88%
3.66
6.30%
3.04
17.06%
3.32
9.16%
invested capital
0.80
-
0.74
8.11%
0.52
29.43%
0.31
39.78%
0.20
35.74%
0.14
31.99%
0.17
23.37%
0.10
41.70%
0.10
1.78%
0.08
14.34%
market cap
9.19T
-
10.45T
13.68%
17.60T
68.48%
13.69T
22.19%
20.11T
46.88%
18.12T
9.92%
21.13T
16.65%
27.15T
28.47%
18.38T
32.28%
12.07T
34.34%
net current asset value
-978.65B
-
-905.58B
7.47%
-768.16B
15.17%
-456.71B
40.54%
-182.01B
60.15%
9.35B
105.14%
-93.51B
1,100.22%
30.55B
132.67%
415.48B
1,260.04%
450.29B
8.38%
net debt to ebitda
1.59
-
1.36
14.23%
0.82
40.00%
0.46
43.95%
0.21
54.16%
0.07
66.40%
0.04
47.27%
0.02
37.00%
-0.13
673.61%
-0.22
60.54%
net income per share
21.31K
-
20.84K
2.20%
27.47K
31.79%
33.91K
23.44%
36.20K
6.76%
40.74K
12.55%
46.43K
13.97%
47.60K
2.51%
50.40K
5.88%
14.11K
72.00%
operating cash flow per share
23.23K
-
27.78K
19.58%
38.05K
36.98%
42.57K
11.86%
43.89K
3.09%
48.76K
11.10%
68.01K
39.47%
59.96K
11.83%
58.75K
2.02%
29.66K
49.50%
payables turnover
10.04
-
10.13
0.91%
10.24
1.12%
10.65
3.97%
10.63
0.18%
12.51
17.66%
10.04
19.76%
11.80
17.53%
11.24
4.75%
14.86
32.29%
receivables turnover
9.62
-
10.49
9.00%
11.56
10.23%
11.68
1.01%
11.14
4.61%
10.19
8.50%
11.07
8.55%
11.56
4.50%
12.65
9.34%
11.09
12.31%
research and ddevelopement to revenue
0.00
-
0.00
6.70%
0.00
40.23%
0.00
15.88%
0.00
11.82%
0.00
9.13%
0.00
8.02%
0.00
28.10%
0.00
29.59%
0.00
15.44%
return on tangible assets
0.17
-
0.14
15.32%
0.16
15.37%
0.18
13.51%
0.18
2.79%
0.18
2.11%
0.17
9.65%
0.17
1.83%
0.16
6.87%
0.05
71.00%
0.02
50.20%
revenue per share
258.03K
-
278.96K
8.11%
317.93K
13.97%
363.62K
14.37%
374.15K
2.90%
402.63K
7.61%
458.61K
13.90%
468.10K
2.07%
482.84K
3.15%
428.64K
11.22%
roe
0.25
-
0.21
15.85%
0.23
5.88%
0.22
0.70%
0.20
9.79%
0.19
3.96%
0.19
3.48%
0.17
10.62%
0.16
6.54%
0.04
71.73%
0.03
33.49%
roic
0.15
-
0.13
12.14%
0.16
21.49%
0.20
26.52%
0.19
8.96%
0.19
1.58%
0.17
12.08%
0.16
1.95%
0.15
5.95%
0.07
51.92%
0.05
29.30%
sales general and administrative to revenue
0.03
-
0.03
9.08%
0.03
11.17%
0.01
48.59%
0.01
5.80%
0.01
0.19%
0.02
24.69%
0.01
10.29%
0.01
1.69%
0.02
20.86%
shareholders equity per share
84.03K
-
97.66K
16.23%
121.56K
24.46%
151.10K
24.31%
178.83K
18.35%
209.57K
17.19%
247.45K
18.07%
283.80K
14.69%
321.52K
13.29%
318.50K
0.94%
stock based compensation to revenue
tangible asset value
189.49B
-
362.38B
91.25%
735.08B
102.85%
1.20T
63.37%
1.69T
40.71%
2.05T
21.26%
2.45T
19.56%
2.79T
13.71%
3.33T
19.50%
3.37T
1.18%
7.22T
114.36%
tangible book value per share
11.30K
-
21.61K
91.25%
43.86K
102.91%
71.66K
63.38%
100.83K
40.71%
122.27K
21.26%
146.18K
19.56%
166.23K
13.71%
198.66K
19.51%
200.92K
1.14%
working capital
-616.74M
-
178.59B
29,056.42%
171.67B
3.87%
277.72B
61.77%
269.29B
3.04%
332.32B
23.41%
391.87B
17.92%
503.05B
28.37%
947.04B
88.26%
1.12T
18.44%

All numbers in (except ratios and percentages)